Global Natamycin Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Natamycin market size is predicted to grow from US$ 206 million in 2025 to US$ 303 million in 2031; it is expected to grow at a CAGR of 6.6% from 2025 to 2031.
Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.
Global Natamycin key players include Danisco, DSM, VGP, Handary, AMTECH BIOTECH, etc. Global top five players hold a share about 50%.
North America is the largest market, with a share about 35%, followed by Europe and China, having a total share about 35 percent.
In terms of product, the segment includes Glucose-based, Lactose-based, Sodium chloride-based. And in terms of application, the application includes Food Industry, Medical, etc.
LP Information, Inc. (LPI) ' newest research report, the “Natamycin Industry Forecast” looks at past sales and reviews total world Natamycin sales in 2024, providing a comprehensive analysis by region and market sector of projected Natamycin sales for 2025 through 2031. With Natamycin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Natamycin industry.
This Insight Report provides a comprehensive analysis of the global Natamycin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Natamycin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Natamycin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Natamycin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Natamycin.
This report presents a comprehensive overview, market shares, and growth opportunities of Natamycin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Natamycin market?
What factors are driving Natamycin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Natamycin market opportunities vary by end market size?
How does Natamycin break out by Type, by Application?
The global Natamycin market size is predicted to grow from US$ 206 million in 2025 to US$ 303 million in 2031; it is expected to grow at a CAGR of 6.6% from 2025 to 2031.
Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.
Global Natamycin key players include Danisco, DSM, VGP, Handary, AMTECH BIOTECH, etc. Global top five players hold a share about 50%.
North America is the largest market, with a share about 35%, followed by Europe and China, having a total share about 35 percent.
In terms of product, the segment includes Glucose-based, Lactose-based, Sodium chloride-based. And in terms of application, the application includes Food Industry, Medical, etc.
LP Information, Inc. (LPI) ' newest research report, the “Natamycin Industry Forecast” looks at past sales and reviews total world Natamycin sales in 2024, providing a comprehensive analysis by region and market sector of projected Natamycin sales for 2025 through 2031. With Natamycin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Natamycin industry.
This Insight Report provides a comprehensive analysis of the global Natamycin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Natamycin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Natamycin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Natamycin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Natamycin.
This report presents a comprehensive overview, market shares, and growth opportunities of Natamycin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Glucose-based
- Lactose-based
- Sodium chloride-based
- Food
- Medical
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Danisco
- DSM
- VGP
- Handary
- AMTECH BIOTECH
- Silver-Elephant
- Lanzhou Weiri
- Langfang Meihua
- Zhengzhou New Frey
- Chihon
- Jiaozuo Joincare
- Beijing Oriental Rada
- Pucheng Lifecome
What is the 10-year outlook for the global Natamycin market?
What factors are driving Natamycin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Natamycin market opportunities vary by end market size?
How does Natamycin break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Natamycin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Natamycin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Natamycin by Country/Region, 2020, 2024 & 2031
2.2 Natamycin Segment by Type
2.2.1 Glucose-based
2.2.2 Lactose-based
2.2.3 Sodium chloride-based
2.3 Natamycin Sales by Type
2.3.1 Global Natamycin Sales Market Share by Type (2020-2025)
2.3.2 Global Natamycin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Natamycin Sale Price by Type (2020-2025)
2.4 Natamycin Segment by Application
2.4.1 Food
2.4.2 Medical
2.4.3 Others
2.5 Natamycin Sales by Application
2.5.1 Global Natamycin Sale Market Share by Application (2020-2025)
2.5.2 Global Natamycin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Natamycin Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Natamycin Breakdown Data by Company
3.1.1 Global Natamycin Annual Sales by Company (2020-2025)
3.1.2 Global Natamycin Sales Market Share by Company (2020-2025)
3.2 Global Natamycin Annual Revenue by Company (2020-2025)
3.2.1 Global Natamycin Revenue by Company (2020-2025)
3.2.2 Global Natamycin Revenue Market Share by Company (2020-2025)
3.3 Global Natamycin Sale Price by Company
3.4 Key Manufacturers Natamycin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Natamycin Product Location Distribution
3.4.2 Players Natamycin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NATAMYCIN BY GEOGRAPHIC REGION
4.1 World Historic Natamycin Market Size by Geographic Region (2020-2025)
4.1.1 Global Natamycin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Natamycin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Natamycin Market Size by Country/Region (2020-2025)
4.2.1 Global Natamycin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Natamycin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Natamycin Sales Growth
4.4 APAC Natamycin Sales Growth
4.5 Europe Natamycin Sales Growth
4.6 Middle East & Africa Natamycin Sales Growth
5 AMERICAS
5.1 Americas Natamycin Sales by Country
5.1.1 Americas Natamycin Sales by Country (2020-2025)
5.1.2 Americas Natamycin Revenue by Country (2020-2025)
5.2 Americas Natamycin Sales by Type (2020-2025)
5.3 Americas Natamycin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Natamycin Sales by Region
6.1.1 APAC Natamycin Sales by Region (2020-2025)
6.1.2 APAC Natamycin Revenue by Region (2020-2025)
6.2 APAC Natamycin Sales by Type (2020-2025)
6.3 APAC Natamycin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Natamycin by Country
7.1.1 Europe Natamycin Sales by Country (2020-2025)
7.1.2 Europe Natamycin Revenue by Country (2020-2025)
7.2 Europe Natamycin Sales by Type (2020-2025)
7.3 Europe Natamycin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Natamycin by Country
8.1.1 Middle East & Africa Natamycin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Natamycin Revenue by Country (2020-2025)
8.2 Middle East & Africa Natamycin Sales by Type (2020-2025)
8.3 Middle East & Africa Natamycin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Natamycin
10.3 Manufacturing Process Analysis of Natamycin
10.4 Industry Chain Structure of Natamycin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Natamycin Distributors
11.3 Natamycin Customer
12 WORLD FORECAST REVIEW FOR NATAMYCIN BY GEOGRAPHIC REGION
12.1 Global Natamycin Market Size Forecast by Region
12.1.1 Global Natamycin Forecast by Region (2026-2031)
12.1.2 Global Natamycin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Natamycin Forecast by Type (2026-2031)
12.7 Global Natamycin Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Danisco
13.1.1 Danisco Company Information
13.1.2 Danisco Natamycin Product Portfolios and Specifications
13.1.3 Danisco Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Danisco Main Business Overview
13.1.5 Danisco Latest Developments
13.2 DSM
13.2.1 DSM Company Information
13.2.2 DSM Natamycin Product Portfolios and Specifications
13.2.3 DSM Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 DSM Main Business Overview
13.2.5 DSM Latest Developments
13.3 VGP
13.3.1 VGP Company Information
13.3.2 VGP Natamycin Product Portfolios and Specifications
13.3.3 VGP Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 VGP Main Business Overview
13.3.5 VGP Latest Developments
13.4 Handary
13.4.1 Handary Company Information
13.4.2 Handary Natamycin Product Portfolios and Specifications
13.4.3 Handary Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Handary Main Business Overview
13.4.5 Handary Latest Developments
13.5 AMTECH BIOTECH
13.5.1 AMTECH BIOTECH Company Information
13.5.2 AMTECH BIOTECH Natamycin Product Portfolios and Specifications
13.5.3 AMTECH BIOTECH Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 AMTECH BIOTECH Main Business Overview
13.5.5 AMTECH BIOTECH Latest Developments
13.6 Silver-Elephant
13.6.1 Silver-Elephant Company Information
13.6.2 Silver-Elephant Natamycin Product Portfolios and Specifications
13.6.3 Silver-Elephant Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Silver-Elephant Main Business Overview
13.6.5 Silver-Elephant Latest Developments
13.7 Lanzhou Weiri
13.7.1 Lanzhou Weiri Company Information
13.7.2 Lanzhou Weiri Natamycin Product Portfolios and Specifications
13.7.3 Lanzhou Weiri Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Lanzhou Weiri Main Business Overview
13.7.5 Lanzhou Weiri Latest Developments
13.8 Langfang Meihua
13.8.1 Langfang Meihua Company Information
13.8.2 Langfang Meihua Natamycin Product Portfolios and Specifications
13.8.3 Langfang Meihua Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Langfang Meihua Main Business Overview
13.8.5 Langfang Meihua Latest Developments
13.9 Zhengzhou New Frey
13.9.1 Zhengzhou New Frey Company Information
13.9.2 Zhengzhou New Frey Natamycin Product Portfolios and Specifications
13.9.3 Zhengzhou New Frey Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Zhengzhou New Frey Main Business Overview
13.9.5 Zhengzhou New Frey Latest Developments
13.10 Chihon
13.10.1 Chihon Company Information
13.10.2 Chihon Natamycin Product Portfolios and Specifications
13.10.3 Chihon Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Chihon Main Business Overview
13.10.5 Chihon Latest Developments
13.11 Jiaozuo Joincare
13.11.1 Jiaozuo Joincare Company Information
13.11.2 Jiaozuo Joincare Natamycin Product Portfolios and Specifications
13.11.3 Jiaozuo Joincare Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Jiaozuo Joincare Main Business Overview
13.11.5 Jiaozuo Joincare Latest Developments
13.12 Beijing Oriental Rada
13.12.1 Beijing Oriental Rada Company Information
13.12.2 Beijing Oriental Rada Natamycin Product Portfolios and Specifications
13.12.3 Beijing Oriental Rada Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Beijing Oriental Rada Main Business Overview
13.12.5 Beijing Oriental Rada Latest Developments
13.13 Pucheng Lifecome
13.13.1 Pucheng Lifecome Company Information
13.13.2 Pucheng Lifecome Natamycin Product Portfolios and Specifications
13.13.3 Pucheng Lifecome Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Pucheng Lifecome Main Business Overview
13.13.5 Pucheng Lifecome Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Natamycin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Natamycin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Glucose-based
Table 4. Major Players of Lactose-based
Table 5. Major Players of Sodium chloride-based
Table 6. Global Natamycin Sales byType (2020-2025) & (MT)
Table 7. Global Natamycin Sales Market Share byType (2020-2025)
Table 8. Global Natamycin Revenue byType (2020-2025) & ($ million)
Table 9. Global Natamycin Revenue Market Share byType (2020-2025)
Table 10. Global Natamycin Sale Price byType (2020-2025) & (USD/MT)
Table 11. Global Natamycin Sale by Application (2020-2025) & (MT)
Table 12. Global Natamycin Sale Market Share by Application (2020-2025)
Table 13. Global Natamycin Revenue by Application (2020-2025) & ($ million)
Table 14. Global Natamycin Revenue Market Share by Application (2020-2025)
Table 15. Global Natamycin Sale Price by Application (2020-2025) & (USD/MT)
Table 16. Global Natamycin Sales by Company (2020-2025) & (MT)
Table 17. Global Natamycin Sales Market Share by Company (2020-2025)
Table 18. Global Natamycin Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Natamycin Revenue Market Share by Company (2020-2025)
Table 20. Global Natamycin Sale Price by Company (2020-2025) & (USD/MT)
Table 21. Key Manufacturers Natamycin Producing Area Distribution and Sales Area
Table 22. Players Natamycin Products Offered
Table 23. Natamycin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Natamycin Sales by Geographic Region (2020-2025) & (MT)
Table 27. Global Natamycin Sales Market Share Geographic Region (2020-2025)
Table 28. Global Natamycin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Natamycin Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Natamycin Sales by Country/Region (2020-2025) & (MT)
Table 31. Global Natamycin Sales Market Share by Country/Region (2020-2025)
Table 32. Global Natamycin Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Natamycin Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Natamycin Sales by Country (2020-2025) & (MT)
Table 35. Americas Natamycin Sales Market Share by Country (2020-2025)
Table 36. Americas Natamycin Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Natamycin Sales byType (2020-2025) & (MT)
Table 38. Americas Natamycin Sales by Application (2020-2025) & (MT)
Table 39. APAC Natamycin Sales by Region (2020-2025) & (MT)
Table 40. APAC Natamycin Sales Market Share by Region (2020-2025)
Table 41. APAC Natamycin Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Natamycin Sales byType (2020-2025) & (MT)
Table 43. APAC Natamycin Sales by Application (2020-2025) & (MT)
Table 44. Europe Natamycin Sales by Country (2020-2025) & (MT)
Table 45. Europe Natamycin Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Natamycin Sales byType (2020-2025) & (MT)
Table 47. Europe Natamycin Sales by Application (2020-2025) & (MT)
Table 48. Middle East & Africa Natamycin Sales by Country (2020-2025) & (MT)
Table 49. Middle East & Africa Natamycin Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Natamycin Sales byType (2020-2025) & (MT)
Table 51. Middle East & Africa Natamycin Sales by Application (2020-2025) & (MT)
Table 52. Key Market Drivers & Growth Opportunities of Natamycin
Table 53. Key Market Challenges & Risks of Natamycin
Table 54. Key IndustryTrends of Natamycin
Table 55. Natamycin Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Natamycin Distributors List
Table 58. Natamycin Customer List
Table 59. Global Natamycin SalesForecast by Region (2026-2031) & (MT)
Table 60. Global Natamycin RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Natamycin SalesForecast by Country (2026-2031) & (MT)
Table 62. Americas Natamycin Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Natamycin SalesForecast by Region (2026-2031) & (MT)
Table 64. APAC Natamycin Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Natamycin SalesForecast by Country (2026-2031) & (MT)
Table 66. Europe Natamycin RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Natamycin SalesForecast by Country (2026-2031) & (MT)
Table 68. Middle East & Africa Natamycin RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Natamycin SalesForecast byType (2026-2031) & (MT)
Table 70. Global Natamycin RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Natamycin SalesForecast by Application (2026-2031) & (MT)
Table 72. Global Natamycin RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Danisco Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 74. Danisco Natamycin Product Portfolios and Specifications
Table 75. Danisco Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 76. Danisco Main Business
Table 77. Danisco Latest Developments
Table 78. DSM Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 79. DSM Natamycin Product Portfolios and Specifications
Table 80. DSM Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. DSM Main Business
Table 82. DSM Latest Developments
Table 83. VGP Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 84. VGP Natamycin Product Portfolios and Specifications
Table 85. VGP Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. VGP Main Business
Table 87. VGP Latest Developments
Table 88. Handary Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 89. Handary Natamycin Product Portfolios and Specifications
Table 90. Handary Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Handary Main Business
Table 92. Handary Latest Developments
Table 93. AMTECH BIOTECH Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 94. AMTECH BIOTECH Natamycin Product Portfolios and Specifications
Table 95. AMTECH BIOTECH Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. AMTECH BIOTECH Main Business
Table 97. AMTECH BIOTECH Latest Developments
Table 98. Silver-Elephant Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 99. Silver-Elephant Natamycin Product Portfolios and Specifications
Table 100. Silver-Elephant Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Silver-Elephant Main Business
Table 102. Silver-Elephant Latest Developments
Table 103. Lanzhou Weiri Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 104. Lanzhou Weiri Natamycin Product Portfolios and Specifications
Table 105. Lanzhou Weiri Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Lanzhou Weiri Main Business
Table 107. Lanzhou Weiri Latest Developments
Table 108. Langfang Meihua Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 109. Langfang Meihua Natamycin Product Portfolios and Specifications
Table 110. Langfang Meihua Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. Langfang Meihua Main Business
Table 112. Langfang Meihua Latest Developments
Table 113. Zhengzhou NewFrey Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 114. Zhengzhou NewFrey Natamycin Product Portfolios and Specifications
Table 115. Zhengzhou NewFrey Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Zhengzhou NewFrey Main Business
Table 117. Zhengzhou NewFrey Latest Developments
Table 118. Chihon Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 119. Chihon Natamycin Product Portfolios and Specifications
Table 120. Chihon Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 121. Chihon Main Business
Table 122. Chihon Latest Developments
Table 123. Jiaozuo Joincare Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 124. Jiaozuo Joincare Natamycin Product Portfolios and Specifications
Table 125. Jiaozuo Joincare Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 126. Jiaozuo Joincare Main Business
Table 127. Jiaozuo Joincare Latest Developments
Table 128. Beijing Oriental Rada Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 129. Beijing Oriental Rada Natamycin Product Portfolios and Specifications
Table 130. Beijing Oriental Rada Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 131. Beijing Oriental Rada Main Business
Table 132. Beijing Oriental Rada Latest Developments
Table 133. Pucheng Lifecome Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 134. Pucheng Lifecome Natamycin Product Portfolios and Specifications
Table 135. Pucheng Lifecome Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 136. Pucheng Lifecome Main Business
Table 137. Pucheng Lifecome Latest Developments
LIST OFFIGURES
Figure 1. Picture of Natamycin
Figure 2. Natamycin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Natamycin Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Natamycin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Natamycin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Natamycin Sales Market Share by Country/Region (2024)
Figure 10. Natamycin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Glucose-based
Figure 12. Product Picture of Lactose-based
Figure 13. Product Picture of Sodium chloride-based
Figure 14. Global Natamycin Sales Market Share byType in 2025
Figure 15. Global Natamycin Revenue Market Share byType (2020-2025)
Figure 16. Natamycin Consumed inFood
Figure 17. Global Natamycin Market:Food (2020-2025) & (MT)
Figure 18. Natamycin Consumed in Medical
Figure 19. Global Natamycin Market: Medical (2020-2025) & (MT)
Figure 20. Natamycin Consumed in Others
Figure 21. Global Natamycin Market: Others (2020-2025) & (MT)
Figure 22. Global Natamycin Sale Market Share by Application (2024)
Figure 23. Global Natamycin Revenue Market Share by Application in 2025
Figure 24. Natamycin Sales by Company in 2025 (MT)
Figure 25. Global Natamycin Sales Market Share by Company in 2025
Figure 26. Natamycin Revenue by Company in 2025 ($ millions)
Figure 27. Global Natamycin Revenue Market Share by Company in 2025
Figure 28. Global Natamycin Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Natamycin Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Natamycin Sales 2020-2025 (MT)
Figure 31. Americas Natamycin Revenue 2020-2025 ($ millions)
Figure 32. APAC Natamycin Sales 2020-2025 (MT)
Figure 33. APAC Natamycin Revenue 2020-2025 ($ millions)
Figure 34. Europe Natamycin Sales 2020-2025 (MT)
Figure 35. Europe Natamycin Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Natamycin Sales 2020-2025 (MT)
Figure 37. Middle East & Africa Natamycin Revenue 2020-2025 ($ millions)
Figure 38. Americas Natamycin Sales Market Share by Country in 2025
Figure 39. Americas Natamycin Revenue Market Share by Country (2020-2025)
Figure 40. Americas Natamycin Sales Market Share byType (2020-2025)
Figure 41. Americas Natamycin Sales Market Share by Application (2020-2025)
Figure 42. United States Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Natamycin Sales Market Share by Region in 2025
Figure 47. APAC Natamycin Revenue Market Share by Region (2020-2025)
Figure 48. APAC Natamycin Sales Market Share byType (2020-2025)
Figure 49. APAC Natamycin Sales Market Share by Application (2020-2025)
Figure 50. China Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 54. India Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Natamycin Sales Market Share by Country in 2025
Figure 58. Europe Natamycin Revenue Market Share by Country (2020-2025)
Figure 59. Europe Natamycin Sales Market Share byType (2020-2025)
Figure 60. Europe Natamycin Sales Market Share by Application (2020-2025)
Figure 61. Germany Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 62.France Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Natamycin Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Natamycin Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Natamycin Sales Market Share by Application (2020-2025)
Figure 69. Egypt Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Natamycin in 2025
Figure 75. Manufacturing Process Analysis of Natamycin
Figure 76. Industry Chain Structure of Natamycin
Figure 77. Channels of Distribution
Figure 78. Global Natamycin Sales MarketForecast by Region (2026-2031)
Figure 79. Global Natamycin Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Natamycin Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Natamycin Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Natamycin Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Natamycin Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Natamycin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Natamycin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Natamycin by Country/Region, 2020, 2024 & 2031
2.2 Natamycin Segment by Type
2.2.1 Glucose-based
2.2.2 Lactose-based
2.2.3 Sodium chloride-based
2.3 Natamycin Sales by Type
2.3.1 Global Natamycin Sales Market Share by Type (2020-2025)
2.3.2 Global Natamycin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Natamycin Sale Price by Type (2020-2025)
2.4 Natamycin Segment by Application
2.4.1 Food
2.4.2 Medical
2.4.3 Others
2.5 Natamycin Sales by Application
2.5.1 Global Natamycin Sale Market Share by Application (2020-2025)
2.5.2 Global Natamycin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Natamycin Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Natamycin Breakdown Data by Company
3.1.1 Global Natamycin Annual Sales by Company (2020-2025)
3.1.2 Global Natamycin Sales Market Share by Company (2020-2025)
3.2 Global Natamycin Annual Revenue by Company (2020-2025)
3.2.1 Global Natamycin Revenue by Company (2020-2025)
3.2.2 Global Natamycin Revenue Market Share by Company (2020-2025)
3.3 Global Natamycin Sale Price by Company
3.4 Key Manufacturers Natamycin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Natamycin Product Location Distribution
3.4.2 Players Natamycin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NATAMYCIN BY GEOGRAPHIC REGION
4.1 World Historic Natamycin Market Size by Geographic Region (2020-2025)
4.1.1 Global Natamycin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Natamycin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Natamycin Market Size by Country/Region (2020-2025)
4.2.1 Global Natamycin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Natamycin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Natamycin Sales Growth
4.4 APAC Natamycin Sales Growth
4.5 Europe Natamycin Sales Growth
4.6 Middle East & Africa Natamycin Sales Growth
5 AMERICAS
5.1 Americas Natamycin Sales by Country
5.1.1 Americas Natamycin Sales by Country (2020-2025)
5.1.2 Americas Natamycin Revenue by Country (2020-2025)
5.2 Americas Natamycin Sales by Type (2020-2025)
5.3 Americas Natamycin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Natamycin Sales by Region
6.1.1 APAC Natamycin Sales by Region (2020-2025)
6.1.2 APAC Natamycin Revenue by Region (2020-2025)
6.2 APAC Natamycin Sales by Type (2020-2025)
6.3 APAC Natamycin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Natamycin by Country
7.1.1 Europe Natamycin Sales by Country (2020-2025)
7.1.2 Europe Natamycin Revenue by Country (2020-2025)
7.2 Europe Natamycin Sales by Type (2020-2025)
7.3 Europe Natamycin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Natamycin by Country
8.1.1 Middle East & Africa Natamycin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Natamycin Revenue by Country (2020-2025)
8.2 Middle East & Africa Natamycin Sales by Type (2020-2025)
8.3 Middle East & Africa Natamycin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Natamycin
10.3 Manufacturing Process Analysis of Natamycin
10.4 Industry Chain Structure of Natamycin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Natamycin Distributors
11.3 Natamycin Customer
12 WORLD FORECAST REVIEW FOR NATAMYCIN BY GEOGRAPHIC REGION
12.1 Global Natamycin Market Size Forecast by Region
12.1.1 Global Natamycin Forecast by Region (2026-2031)
12.1.2 Global Natamycin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Natamycin Forecast by Type (2026-2031)
12.7 Global Natamycin Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Danisco
13.1.1 Danisco Company Information
13.1.2 Danisco Natamycin Product Portfolios and Specifications
13.1.3 Danisco Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Danisco Main Business Overview
13.1.5 Danisco Latest Developments
13.2 DSM
13.2.1 DSM Company Information
13.2.2 DSM Natamycin Product Portfolios and Specifications
13.2.3 DSM Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 DSM Main Business Overview
13.2.5 DSM Latest Developments
13.3 VGP
13.3.1 VGP Company Information
13.3.2 VGP Natamycin Product Portfolios and Specifications
13.3.3 VGP Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 VGP Main Business Overview
13.3.5 VGP Latest Developments
13.4 Handary
13.4.1 Handary Company Information
13.4.2 Handary Natamycin Product Portfolios and Specifications
13.4.3 Handary Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Handary Main Business Overview
13.4.5 Handary Latest Developments
13.5 AMTECH BIOTECH
13.5.1 AMTECH BIOTECH Company Information
13.5.2 AMTECH BIOTECH Natamycin Product Portfolios and Specifications
13.5.3 AMTECH BIOTECH Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 AMTECH BIOTECH Main Business Overview
13.5.5 AMTECH BIOTECH Latest Developments
13.6 Silver-Elephant
13.6.1 Silver-Elephant Company Information
13.6.2 Silver-Elephant Natamycin Product Portfolios and Specifications
13.6.3 Silver-Elephant Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Silver-Elephant Main Business Overview
13.6.5 Silver-Elephant Latest Developments
13.7 Lanzhou Weiri
13.7.1 Lanzhou Weiri Company Information
13.7.2 Lanzhou Weiri Natamycin Product Portfolios and Specifications
13.7.3 Lanzhou Weiri Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Lanzhou Weiri Main Business Overview
13.7.5 Lanzhou Weiri Latest Developments
13.8 Langfang Meihua
13.8.1 Langfang Meihua Company Information
13.8.2 Langfang Meihua Natamycin Product Portfolios and Specifications
13.8.3 Langfang Meihua Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Langfang Meihua Main Business Overview
13.8.5 Langfang Meihua Latest Developments
13.9 Zhengzhou New Frey
13.9.1 Zhengzhou New Frey Company Information
13.9.2 Zhengzhou New Frey Natamycin Product Portfolios and Specifications
13.9.3 Zhengzhou New Frey Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Zhengzhou New Frey Main Business Overview
13.9.5 Zhengzhou New Frey Latest Developments
13.10 Chihon
13.10.1 Chihon Company Information
13.10.2 Chihon Natamycin Product Portfolios and Specifications
13.10.3 Chihon Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Chihon Main Business Overview
13.10.5 Chihon Latest Developments
13.11 Jiaozuo Joincare
13.11.1 Jiaozuo Joincare Company Information
13.11.2 Jiaozuo Joincare Natamycin Product Portfolios and Specifications
13.11.3 Jiaozuo Joincare Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Jiaozuo Joincare Main Business Overview
13.11.5 Jiaozuo Joincare Latest Developments
13.12 Beijing Oriental Rada
13.12.1 Beijing Oriental Rada Company Information
13.12.2 Beijing Oriental Rada Natamycin Product Portfolios and Specifications
13.12.3 Beijing Oriental Rada Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Beijing Oriental Rada Main Business Overview
13.12.5 Beijing Oriental Rada Latest Developments
13.13 Pucheng Lifecome
13.13.1 Pucheng Lifecome Company Information
13.13.2 Pucheng Lifecome Natamycin Product Portfolios and Specifications
13.13.3 Pucheng Lifecome Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Pucheng Lifecome Main Business Overview
13.13.5 Pucheng Lifecome Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Natamycin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Natamycin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Glucose-based
Table 4. Major Players of Lactose-based
Table 5. Major Players of Sodium chloride-based
Table 6. Global Natamycin Sales byType (2020-2025) & (MT)
Table 7. Global Natamycin Sales Market Share byType (2020-2025)
Table 8. Global Natamycin Revenue byType (2020-2025) & ($ million)
Table 9. Global Natamycin Revenue Market Share byType (2020-2025)
Table 10. Global Natamycin Sale Price byType (2020-2025) & (USD/MT)
Table 11. Global Natamycin Sale by Application (2020-2025) & (MT)
Table 12. Global Natamycin Sale Market Share by Application (2020-2025)
Table 13. Global Natamycin Revenue by Application (2020-2025) & ($ million)
Table 14. Global Natamycin Revenue Market Share by Application (2020-2025)
Table 15. Global Natamycin Sale Price by Application (2020-2025) & (USD/MT)
Table 16. Global Natamycin Sales by Company (2020-2025) & (MT)
Table 17. Global Natamycin Sales Market Share by Company (2020-2025)
Table 18. Global Natamycin Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Natamycin Revenue Market Share by Company (2020-2025)
Table 20. Global Natamycin Sale Price by Company (2020-2025) & (USD/MT)
Table 21. Key Manufacturers Natamycin Producing Area Distribution and Sales Area
Table 22. Players Natamycin Products Offered
Table 23. Natamycin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Natamycin Sales by Geographic Region (2020-2025) & (MT)
Table 27. Global Natamycin Sales Market Share Geographic Region (2020-2025)
Table 28. Global Natamycin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Natamycin Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Natamycin Sales by Country/Region (2020-2025) & (MT)
Table 31. Global Natamycin Sales Market Share by Country/Region (2020-2025)
Table 32. Global Natamycin Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Natamycin Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Natamycin Sales by Country (2020-2025) & (MT)
Table 35. Americas Natamycin Sales Market Share by Country (2020-2025)
Table 36. Americas Natamycin Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Natamycin Sales byType (2020-2025) & (MT)
Table 38. Americas Natamycin Sales by Application (2020-2025) & (MT)
Table 39. APAC Natamycin Sales by Region (2020-2025) & (MT)
Table 40. APAC Natamycin Sales Market Share by Region (2020-2025)
Table 41. APAC Natamycin Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Natamycin Sales byType (2020-2025) & (MT)
Table 43. APAC Natamycin Sales by Application (2020-2025) & (MT)
Table 44. Europe Natamycin Sales by Country (2020-2025) & (MT)
Table 45. Europe Natamycin Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Natamycin Sales byType (2020-2025) & (MT)
Table 47. Europe Natamycin Sales by Application (2020-2025) & (MT)
Table 48. Middle East & Africa Natamycin Sales by Country (2020-2025) & (MT)
Table 49. Middle East & Africa Natamycin Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Natamycin Sales byType (2020-2025) & (MT)
Table 51. Middle East & Africa Natamycin Sales by Application (2020-2025) & (MT)
Table 52. Key Market Drivers & Growth Opportunities of Natamycin
Table 53. Key Market Challenges & Risks of Natamycin
Table 54. Key IndustryTrends of Natamycin
Table 55. Natamycin Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Natamycin Distributors List
Table 58. Natamycin Customer List
Table 59. Global Natamycin SalesForecast by Region (2026-2031) & (MT)
Table 60. Global Natamycin RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Natamycin SalesForecast by Country (2026-2031) & (MT)
Table 62. Americas Natamycin Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Natamycin SalesForecast by Region (2026-2031) & (MT)
Table 64. APAC Natamycin Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Natamycin SalesForecast by Country (2026-2031) & (MT)
Table 66. Europe Natamycin RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Natamycin SalesForecast by Country (2026-2031) & (MT)
Table 68. Middle East & Africa Natamycin RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Natamycin SalesForecast byType (2026-2031) & (MT)
Table 70. Global Natamycin RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Natamycin SalesForecast by Application (2026-2031) & (MT)
Table 72. Global Natamycin RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Danisco Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 74. Danisco Natamycin Product Portfolios and Specifications
Table 75. Danisco Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 76. Danisco Main Business
Table 77. Danisco Latest Developments
Table 78. DSM Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 79. DSM Natamycin Product Portfolios and Specifications
Table 80. DSM Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. DSM Main Business
Table 82. DSM Latest Developments
Table 83. VGP Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 84. VGP Natamycin Product Portfolios and Specifications
Table 85. VGP Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. VGP Main Business
Table 87. VGP Latest Developments
Table 88. Handary Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 89. Handary Natamycin Product Portfolios and Specifications
Table 90. Handary Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Handary Main Business
Table 92. Handary Latest Developments
Table 93. AMTECH BIOTECH Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 94. AMTECH BIOTECH Natamycin Product Portfolios and Specifications
Table 95. AMTECH BIOTECH Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. AMTECH BIOTECH Main Business
Table 97. AMTECH BIOTECH Latest Developments
Table 98. Silver-Elephant Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 99. Silver-Elephant Natamycin Product Portfolios and Specifications
Table 100. Silver-Elephant Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Silver-Elephant Main Business
Table 102. Silver-Elephant Latest Developments
Table 103. Lanzhou Weiri Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 104. Lanzhou Weiri Natamycin Product Portfolios and Specifications
Table 105. Lanzhou Weiri Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Lanzhou Weiri Main Business
Table 107. Lanzhou Weiri Latest Developments
Table 108. Langfang Meihua Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 109. Langfang Meihua Natamycin Product Portfolios and Specifications
Table 110. Langfang Meihua Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. Langfang Meihua Main Business
Table 112. Langfang Meihua Latest Developments
Table 113. Zhengzhou NewFrey Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 114. Zhengzhou NewFrey Natamycin Product Portfolios and Specifications
Table 115. Zhengzhou NewFrey Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Zhengzhou NewFrey Main Business
Table 117. Zhengzhou NewFrey Latest Developments
Table 118. Chihon Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 119. Chihon Natamycin Product Portfolios and Specifications
Table 120. Chihon Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 121. Chihon Main Business
Table 122. Chihon Latest Developments
Table 123. Jiaozuo Joincare Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 124. Jiaozuo Joincare Natamycin Product Portfolios and Specifications
Table 125. Jiaozuo Joincare Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 126. Jiaozuo Joincare Main Business
Table 127. Jiaozuo Joincare Latest Developments
Table 128. Beijing Oriental Rada Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 129. Beijing Oriental Rada Natamycin Product Portfolios and Specifications
Table 130. Beijing Oriental Rada Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 131. Beijing Oriental Rada Main Business
Table 132. Beijing Oriental Rada Latest Developments
Table 133. Pucheng Lifecome Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors
Table 134. Pucheng Lifecome Natamycin Product Portfolios and Specifications
Table 135. Pucheng Lifecome Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 136. Pucheng Lifecome Main Business
Table 137. Pucheng Lifecome Latest Developments
LIST OFFIGURES
Figure 1. Picture of Natamycin
Figure 2. Natamycin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Natamycin Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Natamycin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Natamycin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Natamycin Sales Market Share by Country/Region (2024)
Figure 10. Natamycin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Glucose-based
Figure 12. Product Picture of Lactose-based
Figure 13. Product Picture of Sodium chloride-based
Figure 14. Global Natamycin Sales Market Share byType in 2025
Figure 15. Global Natamycin Revenue Market Share byType (2020-2025)
Figure 16. Natamycin Consumed inFood
Figure 17. Global Natamycin Market:Food (2020-2025) & (MT)
Figure 18. Natamycin Consumed in Medical
Figure 19. Global Natamycin Market: Medical (2020-2025) & (MT)
Figure 20. Natamycin Consumed in Others
Figure 21. Global Natamycin Market: Others (2020-2025) & (MT)
Figure 22. Global Natamycin Sale Market Share by Application (2024)
Figure 23. Global Natamycin Revenue Market Share by Application in 2025
Figure 24. Natamycin Sales by Company in 2025 (MT)
Figure 25. Global Natamycin Sales Market Share by Company in 2025
Figure 26. Natamycin Revenue by Company in 2025 ($ millions)
Figure 27. Global Natamycin Revenue Market Share by Company in 2025
Figure 28. Global Natamycin Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Natamycin Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Natamycin Sales 2020-2025 (MT)
Figure 31. Americas Natamycin Revenue 2020-2025 ($ millions)
Figure 32. APAC Natamycin Sales 2020-2025 (MT)
Figure 33. APAC Natamycin Revenue 2020-2025 ($ millions)
Figure 34. Europe Natamycin Sales 2020-2025 (MT)
Figure 35. Europe Natamycin Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Natamycin Sales 2020-2025 (MT)
Figure 37. Middle East & Africa Natamycin Revenue 2020-2025 ($ millions)
Figure 38. Americas Natamycin Sales Market Share by Country in 2025
Figure 39. Americas Natamycin Revenue Market Share by Country (2020-2025)
Figure 40. Americas Natamycin Sales Market Share byType (2020-2025)
Figure 41. Americas Natamycin Sales Market Share by Application (2020-2025)
Figure 42. United States Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Natamycin Sales Market Share by Region in 2025
Figure 47. APAC Natamycin Revenue Market Share by Region (2020-2025)
Figure 48. APAC Natamycin Sales Market Share byType (2020-2025)
Figure 49. APAC Natamycin Sales Market Share by Application (2020-2025)
Figure 50. China Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 54. India Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Natamycin Sales Market Share by Country in 2025
Figure 58. Europe Natamycin Revenue Market Share by Country (2020-2025)
Figure 59. Europe Natamycin Sales Market Share byType (2020-2025)
Figure 60. Europe Natamycin Sales Market Share by Application (2020-2025)
Figure 61. Germany Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 62.France Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Natamycin Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Natamycin Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Natamycin Sales Market Share by Application (2020-2025)
Figure 69. Egypt Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Natamycin Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Natamycin in 2025
Figure 75. Manufacturing Process Analysis of Natamycin
Figure 76. Industry Chain Structure of Natamycin
Figure 77. Channels of Distribution
Figure 78. Global Natamycin Sales MarketForecast by Region (2026-2031)
Figure 79. Global Natamycin Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Natamycin Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Natamycin Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Natamycin Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Natamycin Revenue Market ShareForecast by Application (2026-2031)
